SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Labwire Inc.
LBWR 0.00010000.0%Oct 24 3:23 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rogerover who wrote (1243)9/9/2008 7:53:18 PM
From: creede1 Recommendation   of 1698
 
Business plan is designed to keep costs low, and margins high. Just as they PRed, I expect the largest revenue gains to come in Q3 and Q4. Check out this post from iHub.

Posted by: airdale1 Date: Tuesday, September 09, 2008 12:58:29 PM
In reply to: None Post # of 7679

Some notables from the 2nd quarter 10Q, this is a healthy company. They have income and are controlling expenses well. We are a far stronger firm this quarter due to the following:

Good and very good-
-A/R Reduced from $1,102,030 to $705,073, almost 400k. Very nice to see them controlling their A/R account
-Prepaid Expenses up from $20,696 to $135K. Shows cashflow is strong
-A/P big drop of over half a million dollars
-Income taxes payable down $11,000
-Notes payable to related parties of $156k is now gone
-Available cash is up to $50k, a nice situation

The biggest negative is the long term debt.

Long term debt went up $348k. Probably based on the payback of the Notes payable to related party and a transfer of some accrued expenses to long term.

Even with the rise in long term debt, the total liabilities dropped $550K, almost 38%, very impressive.

siliconinvestor.com

GB-ND
c
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext